Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-464-976"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-464-976"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-464-9722
lpv:speaker	lp:Silvia-Adriana Țicău2
lpv:spokenAs	unknown; Partidul Social Democrat (2009-07-14--2014-06-30)3 member; Delegation for relations with India (2009-09-16--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the Mercosur countries (2009-09-16--2014-06-30)3 substitute; ITRE (2012-01-19--2014-06-30)3 vice-chair; TRAN (2012-01-23--2014-06-30)3
lpv:translated text	"I voted for the report on discharge in respect of the implementation of the budget of the European Medicines Agency for the financial year 2010. I would like to stress the importance of the Agency’s activities in offering the best possible scientific advice on any question relating to the evaluation of the quality, the safety and the efficacy of medicinal products for human and veterinary use to the Member States and the institutions. I welcome the efforts to reform the payment system for services provided by Member States’ authorities, which, clearly, ought to be based on real costs. I think that a high level of reliability concerning the declaration of interests can only be achieved if pharmaceutical companies themselves make public their list of experts and research centres with which they work, and the sums concerned in their financial links with them. Thought should be given to whether a legislative initiative in this area would be pertinent. Also, the Agency should introduce in each of its annual activity reports a special section describing the actions taken to prevent and manage conflict of interest."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph